Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions

Journal of Analytical Toxicology

Volumn 28, Issue 7, 2004, Pages 616-624

  Cone, Edward J ^a   Fant, Reginald V ^a   Rohay, Jeffrey M ^a   Caplan, Yale H ^b   Ballina, Mayra ^c   Reder, Robert F ^c   Haddox, J David ^c  

^a PINNEY ASSOCIATES   (United States)

^b National Scientific Services   (United States)

^c PURDUE PHARMA L P   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; CANNABIS; CARISOPRODOL; COCAINE; CODEINE; CYCLOBENZAPRINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; HYDROCODONE; MEPROBAMATE; METHADONE; MORPHINE; NORTRIPTYLINE; OXAZEPAM; OXYCODONE; PROMETHAZINE; SERTRALINE; TEMAZEPAM;

ACCIDENTAL DEATH; ADULT; ARTICLE; AUTOPSY; CAUSE OF DEATH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG INTOXICATION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MORTALITY; MULTIPLE DRUG ABUSE; SUICIDE;

ANIMALIA; CANNABIS; GADUS MORHUA;

EID: 4744338365     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/28.7.616     Document Type: Article

References (29)

1. S. Darke and W. Hall. Levels and correlates of polydrug use among heroin users and regular amphetamine users. Drug Alcohol Depend. 39: 231-235 (1995).
2. K. Puschel. Drug-related death - an update. Forensic Sci. Int. 62: 121-128 (1993).
3. S. Darke, S. Sunjic, D. Zador, and T. Prolov. A comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia. Drug Alcohol Depend. 47: 45-53 (1997).
4. R. Penning, E. Fromm, P. Betz, G. Kauert, G. Drasch, and L. von Meyer. Drug death autopsies at the Munich Institute of Forensic Medicine (1981-1992). Forensic Sci. Int. 62: 135-139 (1993).
5. S. Darke and D. Zador. Fatal heroin 'overdose': a review. Addiction 91: 1765-1772 (1996).
6. M. Gossop, D. Stewart, S. Treacy, and J. Marsden. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction 97: 39-47 (2002).
7. D. Zador, S. Sunjic, and S. Darke. Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med. J. Aust. 164: 204-207 (1996).
8. R.G. Richards, D. Reed, and R.H. Cravey. Death from intravenously administered narcotics: a study of 114 cases. J. Forensic Sci. 21: 467-482 (1976).
9. R.R. Clayton. Multiple drug use. Epidemiology, correlates, and consequences. Recent Dev. Alcohol 4: 7-38 (1986).
10. T. Reisine and G. Pasternak. Opioid analgesics and antagonists. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman, Eds. McGraw-Hill, New York, NY, 1996, pp 521-555.
11. S.A. Moallem. Opioids and opiates. In Handbook of Forensic Drug Interactions, A. Mozayani and L.P. Raymon, Eds. Humana Press, Totowa, NJ, 2003.
12. J.D. Leander and J.B. Lucot. Toxic interactions of stimulants, narcotics and narcotic antagonists. Res. Commun. Chem. Pathol. Pharmacol. 17: 255-264 (1977).
13. A.K. Rattan and P. Sribanditmongkol. Effect of morphine-induced catalepsy, lethality, and analgesia by a benzodiazepine receptor agonist midazolam in the rat. Pharmacol. Biochem. Behav. 48: 357-361 (1994).
14. A. Poling, R.G. Sewell, Jr., J.A. Gallus, and N.I. Nearchou. Lethality of opioid and antihistaminic combinations in mice. Pharmacol. Biochem. Behav. 22: 333-335 (1985).
15. M. Garty, Z. Ben Zvi, and A. Hurwitz. Opioid effects on lidocaine disposition and toxicity in mice. J. Pharmacol. Exp. Ther. 234: 391-394 (1985).
16. J.M. White and R.J. Irvine. Mechanisms of fatal opioid overdose. Addiction 94: 961-972 (1999).
17. P.N. Gueye, S.W. Borron, P. Risede, C. Monier, F. Buneaux, M. Debray, and F.J. Baud. Buprenorphine and midazolam act in combination to depress respiration in rats. Toxicol. Sci. 65: 107-114 (2002).
18. C. Poulin, J. Stein, and J. Butt. Surveillance of drug overdose deaths using medical examiner data. Chronic. Dis. Can. 19: 177-182 (1998).
19. P.W. Haberman, J.A. Noble, and M.C. Dufour. Alcohol use in combination with cocaine, heroin and methadone by medical examiner cases. J. Stud. Alcohol 56: 344-347 (1995).
20. M.J. Burt, J. Kloss, and F.S. Apple. Postmortem blood free and total morphine concentrations in medical examiner cases. J. Forensic Sci. 46: 1138-1142 (2001).
21. A.J. Ruttenber, H.D. Kalter, and P. Santinga. The role of ethanol abuse in the etiology of heroin-related death. J. Forensic Sci. 35: 891-900 (1990).
22. G.L. Henderson. Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases. J. Forensic Sci. 36: 422-433 (1991).
23. B. Levine, D. Green, and J.E. Smialek. The role of ethanol in heroin deaths. J. Forensic Sci. 40: 808-810 (1995).
24. S. Darke, J. Ross, D. Zador, and S. Sunjic. Heroin-related deaths in New South Wales, Australia, 1992-1996. Drug Alcohol Depend. 60: 141-150 (2000).
25. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Mortality Data From the Drug Abuse Warning Network, 2001. DAWN Series D-23, DHHS Publication No. (SMA) 03-3781:1-143 (2002).
26. E.J. Cone, R.V. Fant, Y.H. Caplan, M. Ballina, R.F. Reder, D. Spyker, and J.D. Haddox. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J. Anal. Toxicol. 27: 57-67 (2003).
27. O.H. Drummer, M.L. Syrjanen, M. Phelan, and S.M. Cordner. A study of deaths involving oxycodone. J. Forensic Sci. 39: 1069-1075 (1994).
28. G.R. Jones. Interpretation of postmortem drug levels. In Drug Abuse Handbook, S.B. Karch, Ed. CRC Press, Boca Raton, FL, 1998, pp 970-985.
29. D.S. Isenschmid and Y.H. Caplan. Incidence of cannabinoids in medical examiner urine specimens. J. Forensic Sci. 33: 1421-1431 (1988).